The clinical impact of COVID-19 on patients with cancer in British Columbia: An observational study
Open Access
Abstract
No abstract availableKeywords
Funding Information
- BC Cancer Foundation
This publication has 19 references indexed in Scilit:
- Covid-19 and lung cancer: A greater fatality rate?Lung Cancer, 2020
- Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in ItalyJAMA, 2020
- Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple MyelomaFrontiers in Oncology, 2020
- Lung cancer–associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell–immune cell cross-talkScience Translational Medicine, 2017
- T ranslational A dvances in the F ield of P ulmonary H ypertension . From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling HubsAmerican Journal of Respiratory and Critical Care Medicine, 2017
- Novel and Emerging Therapies for Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2014
- Pathogenesis of pulmonary arterial hypertension: lessons from cancerEuropean Respiratory Review, 2013
- Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trialArthritis & Rheumatism, 2009
- Impact of comorbidity on lung cancer survivalInternational Journal of Cancer, 2002
- Impact of comorbidity on survival after surgical resection in patients with stage I non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2002